Relapsed/Refractory Mantle Cell Lymphoma
Also known as: Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09054 | Idelalisib | 1 | Completed | 1 |
DB00480 | Lenalidomide | 1 | Completed | 1 |
DB13915 | Axicabtagene ciloleucel | 2 | Completed | 1 |
DB15699 | Brexucabtagene autoleucel | 2 | Active Not Recruiting | 1 |
DB15699 | Brexucabtagene autoleucel | 2 | Completed | 1 |
DB15699 | Brexucabtagene autoleucel | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 2 | Completed | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB09053 | Ibrutinib | 2 | Completed | 1 |
DB00480 | Lenalidomide | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Completed | 1 |